Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

IntelligentMDx HSV molecular diagnostic assay wins CE mark

IntelligentMDx has received CE mark approval for its automated molecular HSV-1/2 test, designed for the Abbott m2000 system.

The HSV-1/2 for Abbott m2000 assay detects Herpes Simplex Virus (HSV) viral DNA and differentiates HSV-1 and HSV-2 in male and female genital or oral lesions and cerebral spinal fluid.

IntelligentMDx said the HSV-1/2 for Abbott m2000 assay tests up to 94 patient swab samples simultaneously in less than six hours.

The automated molecular test demonstrated 100.0% sensitivity and 97.2% specificity for HSV-1, while 100.0% sensitivity and 98.8% specificity for HSV-2, as compared to clinical samples classified for HSV-1 and HSV-2 using culture and a molecular reference method.

In addition to differentiation of HSV-1 and HSV-2 viruses, the company’s test menu for use on the Abbott m2000 system can detect Group B Streptococcus, vancomycin resistant Enterococci (vanA/ vanB) and toxigenic C. difficile.

IntelligentMDx chairman and CEO Alice Jacobs said, "The robust performance and automated nature of the IMDx HSV-1/2 for Abbott m2000 assay can aid in the diagnosis of patients and support faster treatment decisions."

IntelligentMDx said the HSV-1/2 for Abbott m2000 assay is not available for sale in the US or Canada.